/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Longeveron Inc Share Price Today: Live Updates & Key Insights

Longeveron Inc share price today is $0.86, up -0.43%. The stock opened at $0.78115 against the previous close of $0.8125, with an intraday high of $0.94 and low of $0.7151.

Longeveron Inc Share Price Chart

style
pb-0

Longeveron Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Longeveron Inc Share Price Performance

$0.86 -0.0043(-0.43%) LGVN at 13 Mar 2026 01:58 PM Biotechnology
Lowest Today 0.7151
Highest Today 0.94
Today’s Open 0.78115
Prev. Close 0.8125
52 Week High 1.92
52 Week Low 0.48
Day’s Range: Low 0.7151 High 0.94
52-Week Range: Low 0.48 High 1.92
1 day return -
1 Week return +64.5
1 month return +47.32
3 month return +45.42
6 month return +6.19
1 year return -51.07
3 year return -97.23
5 year return -98.93
10 year return -

Longeveron Inc Institutional Holdings

Vanguard Group Inc 2.34

Vanguard Total Stock Mkt Idx Inv 1.69

Geode Capital Management, LLC 0.66

Vanguard Institutional Extnd Mkt Idx Tr 0.46

Fidelity Extended Market Index 0.33

UBS Group AG 0.30

NT Ext Equity Mkt Idx Fd - L 0.22

State Street Corp 0.21

Jane Street Group LLC 0.21

Capital Investment Advisory Services, LLC 0.12

Commonwealth Equity Services Inc 0.12

Fidelity Total Market Index 0.11

Hamilton Point Investment Advisors, LLC 0.11

Fidelity Series Total Market Index 0.10

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.09

Northern Trust Corp 0.07

Spartan Extended Market Index Pool F 0.07

Northern Trust Extended Eq Market Idx 0.07

Virtu Financial LLC 0.07

TWO SIGMA SECURITIES, LLC 0.06

Moneta Group Investment Advisors Inc 0.06

HRT FINANCIAL LLC 0.06

Lido Advisors, LLC 0.05

BlackRock Inc 0.05

Bank of Montreal 0.05

BMO Capital Markets Corp. 0.05

Spartan Total Market Index Pool G 0.03

Fidelity Nasdaq Composite Index 0.01

Steward Partners Investment Advisory, LLC 0.01

Tower Research Capital LLC 0.01

Advisor Group Holdings, Inc. 0.01

Blackrock Extended Mkt Fund CF 0.01

Extended Equity Market Fund K 0.01

NT Ext Equity Mkt Idx Fd - NL 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

Extended Equity Market Fund M 0.00

State St US Extended Mkt Indx NL Cl C 0.00

State St US Ttl Mkt Indx NL Cl A 0.00

NT US Market Cap Idx Fd - L 0.00

SSgA U.S. Total Market Index Strategy 0.00

Longeveron Inc Market Status

Strong Buy: 0

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Longeveron Inc Fundamentals

Market Cap 14.72 M

PB Ratio 1.7392

PE Ratio 0.0

Enterprise Value 9.07 M

Total Assets 25.56 M

Volume 7156675

Longeveron Inc Company Financials

Annual Revenue FY23:767000 0.8M, FY22:1222000 1.2M, FY21:1306000 1.3M, FY20:5629531 5.6M, FY19:5639466 5.6M

Annual Profit FY23:168000 0.2M, FY22:497000 0.5M, FY21:590000 0.6M, FY20:1826270 1.8M, FY19:1754076 1.8M

Annual Net worth FY23:-19842000 -19.8M, FY22:-19627000 -19.6M, FY21:-17164000 -17.2M, FY20:-3791220 -3.8M, FY19:-2995507 -3.0M

Quarterly Revenue Q3/2025:137000 0.1M, Q2/2025:316000 0.3M, Q1/2025:381000 0.4M, Q3/2024:773000 0.8M, Q2/2024:468000 0.5M

Quarterly Profit Q3/2025:125000 0.1M, Q2/2025:146000 0.1M, Q1/2025:275000 0.3M, Q3/2024:682000 0.7M, Q2/2024:344000 0.3M

Quarterly Net worth Q3/2025:-7221000 -7.2M, Q2/2025:-5028000 -5.0M, Q1/2025:-5011000 -5.0M, Q3/2024:-4419000 -4.4M, Q2/2024:-3413000 -3.4M

About Longeveron Inc & investment objective

Company Information Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.

Organisation Biotechnology

Employees 25

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow